Jia Lu Wu
Director/Board Member at Chengdu Aixing Biotech Co. Ltd.
Profile
Jia Lu Wu has worked as a Director at Chengdu Aixing Biotech Co. Ltd.
and as a Member-Supervisory Board at Shanghai Pinnacles Medical Technology Co., Ltd.
Jia Lu Wu active positions
Companies | Position | Start |
---|---|---|
Chengdu Aixing Biotech Co. Ltd.
Chengdu Aixing Biotech Co. Ltd. Packaged SoftwareTechnology Services Chengdu Aixing Biotech Co. Ltd. is a company founded in 2013 that develops a point of care testing platform. The company is based in Chengdu, China. | Director/Board Member | - |
Shanghai Pinnacles Medical Technology Co., Ltd.
Shanghai Pinnacles Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology Shanghai Pinnacles Medical Technology Co., Ltd. is a company that focuses on becoming a leading enterprise in the field of smart inspection and precise diagnosis. The company is based in Shanghai, China. The Chinese company aims to provide complete solutions for future inspection needs by combining cross-border technologies and focusing on creating a smart inspection and in vitro diagnostic ecosystem. The company was founded in 2020 by Wei Ding, who has been the CEO since 2020. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Chengdu Aixing Biotech Co. Ltd.
Chengdu Aixing Biotech Co. Ltd. Packaged SoftwareTechnology Services Chengdu Aixing Biotech Co. Ltd. is a company founded in 2013 that develops a point of care testing platform. The company is based in Chengdu, China. | Technology Services |
Shanghai Pinnacles Medical Technology Co., Ltd.
Shanghai Pinnacles Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology Shanghai Pinnacles Medical Technology Co., Ltd. is a company that focuses on becoming a leading enterprise in the field of smart inspection and precise diagnosis. The company is based in Shanghai, China. The Chinese company aims to provide complete solutions for future inspection needs by combining cross-border technologies and focusing on creating a smart inspection and in vitro diagnostic ecosystem. The company was founded in 2020 by Wei Ding, who has been the CEO since 2020. | Health Technology |
- Stock Market
- Insiders
- Jia Lu Wu